Table 3. Laboratory data of patients at enrollment and at 6–9 Months.

	Cilostazol (+) (n = 22)			Cilostazol (−) (n = 22)
	Enrollment	At 6–9 months	P-value	Enrollment	At 6–9 months	P-value
Cre, mg/dl	0.81 ± 0.14	0.82 ± 0.17	0.33	0.88 ± 0.24	0.87 ± 0.27	0.37
LDL cholesterol, mg/dl	110 ± 27	103 ± 24	0.30	102 ± 35	90 ± 28	0.16
HDL cholesterol, mg/dl	54 ± 18	58 ± 20	0.07	50 ± 10	53 ± 11	0.01
LDL/HDL ratio	2.2 ± 1.1	2.0 ± 0.9	0.01	2.1 ± 0.8	1.8 ± 0.8	0.02
TG, mg/dl	134 ± 52	130 ± 50	0.56	142 ± 93	156 ± 82	0.53
Hb A1c, %	6.4 ± 0.8	6.6 ± 1.1	0.31	6.7 ± 1.3	6.6 ± 1.2	0.87
BNP, pg/ml	63 ± 121	24 ± 19	0.01	69 ± 96	62 ± 90	0.68

The data are shown as the mean ± SD. Cre, serum creatine; TG, triglyceride; Hb A1c, hemoglobin A1c; BNP, brain natrium peptide.